Carbamazepine 100 MG Oral Tablet — RxCUI 197441
RxNorm drug concept · Semantic clinical drug
RxCUI 197441
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197441
Official nameCarbamazepine 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)28,005 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Carbamazepine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That depends on why your doctor prescribed it. If you have epilepsy, it helps prevent certain types of seizures by calming overactive electrical signals in the brain. If you have t...
- What exactly is carbamazepine supposed to do for me?
- Please don't stop it suddenly without talking to your doctor first — this is really important. Stopping carbamazepine abruptly can trigger serious seizures or even a dangerous cond...
- Can I just stop taking it if I feel better or if I don't like the side effects?
🕸️ Concept Web — How Carbamazepine 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carbamazepine 100 MG Oral Tablet
RxCUI 197441 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Carbamazepine
2002IN
-
Carbamazepine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carbamazepine Oral Tablet
371260SCDF -
Carbamazepine Oral Product
1155760SCDG -
Carbamazepine Pill
1155761SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Carbamazepine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carbamazepine 100 MG
315563SCDC
-
Carbamazepine 100 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carbamazepine 100 MG
SCDC · 315563 -
Carbamazepine Oral Tablet
SCDF · 371260 -
Carbamazepine Oral Product
SCDG · 1155760 -
Carbamazepine Pill
SCDG · 1155761
📦 FDA Products & Package NDCs
4 products · 8 package NDCs
8 package NDCs map to RxCUI 197441 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 60290-0008-01 | 100 TABLET in 1 BOTTLE (60290-008-01) | Carbamazepine | Umedica Laboratories USA Inc. | 2020-04-21 |
| 60290-0008-02 | 1000 TABLET in 1 BOTTLE (60290-008-02) | Carbamazepine | Umedica Laboratories USA Inc. | 2020-04-21 |
| 60290-0034-02 | 100 TABLET in 1 BOTTLE (60290-034-02) | Carbamazepine | Umedica Laboratories USA Inc. | 2020-04-21 |
| 60290-0034-03 | 1000 TABLET in 1 BOTTLE (60290-034-03) | Carbamazepine | Umedica Laboratories USA Inc. | 2020-04-21 |
| 75834-0220-00 | 1000 TABLET in 1 BOTTLE (75834-220-00) | Carbamazepine | NIVAGEN PHARMACEUTICALS, INC. | 2020-04-21 |
| 75834-0220-01 | 100 TABLET in 1 BOTTLE (75834-220-01) | Carbamazepine | NIVAGEN PHARMACEUTICALS, INC. | 2020-04-21 |
| 75834-0221-00 | 1000 TABLET in 1 BOTTLE (75834-221-00) | Carbamazepine | NIVAGEN PHARMACEUTICALS, INC. | 2020-04-21 |
| 75834-0221-01 | 100 TABLET in 1 BOTTLE (75834-221-01) | Carbamazepine | NIVAGEN PHARMACEUTICALS, INC. | 2020-04-21 |
Observed labelers:
NIVAGEN PHARMACEUTICALS, INC. (4) ·
Umedica Laboratories USA Inc. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.